BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28763883)

  • 1. [Association between the ApoB/A1 ratio and the vulnerability of LMCA plaque in the patients with stable angina pectoris].
    Han Y; Yang CK; Gao CY; Liu YH; Cheng JT; Wang XP; Wang ZM; Cheng TF
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(27):2101-2106. PubMed ID: 28763883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association between Lipoprotein(a) and the characteristics of left main coronary artery plaque in patients with stable angina pectoris].
    Han Y; Yang CK; Gao CY; Liu YH; Cheng JT; Wang XP; Wang ZM; Wu XJ; Xu CY
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(19):1490-1493. PubMed ID: 31137140
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the low- to high-density lipoprotein cholesterol ratio on composition of angiographically ambiguous left main coronary artery plaque.
    Kurebayashi N; Yoshikawa D; Ishii H; Sato B; Ando H; Okada T; Hayakawa S; Okumura N; Isobe S; Takeshita K; Hayashi M; Uetani T; Amano T; Murohara T
    Circ J; 2011; 75(8):1960-7. PubMed ID: 21646726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.
    Lin T; Wang L; Guo J; Liu P; Chen L; Wei M; Li G
    Angiology; 2018 Sep; 69(8):724-729. PubMed ID: 29310455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
    Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
    Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease.
    Ohwada T; Sakamoto T; Kanno Y; Yokokawa S; Amami K; Nakazato K; Takeishi Y; Watanabe K
    PLoS One; 2019; 14(2):e0212539. PubMed ID: 30779793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of the Apolipoprotein B/Apolipoprotein A1 Ratio in Predicting the Rapid Progression of Non-Culprit Coronary Lesions in Acute Coronary Syndrome in Patients with Diabetes Mellitus after Percutaneous Coronary Intervention.
    Zhou Y; Liu H; Yang H; Zhao X; Jiao Y
    Int Heart J; 2023 Jul; 64(4):562-569. PubMed ID: 37460319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of serum lipid level with ischemic stroke in the elderly of Xinjiang.
    Yue YH; Bai XD; Li YM; Hu L; Liu LY; Mao JP; Yang XY; Dila NM
    Neuro Endocrinol Lett; 2019 Mar; 39(8):572-578. PubMed ID: 30927763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression.
    Masson W; Siniawski D; Lobo M; Molinero G; Giorgi M; Huerín M
    Arq Bras Cardiol; 2015 Jul; 105(1):11-9. PubMed ID: 26016784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Remnant Lipoprotein on Coronary Plaque Components.
    Matsuo N; Matsuoka T; Onishi S; Yamamoto H; Kato A; Makino Y; Kihara S
    J Atheroscler Thromb; 2015 Aug; 22(8):783-95. PubMed ID: 25739822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.
    Păunică I; Mihai AD; Ștefan S; Pantea-Stoian A; Serafinceanu C
    J Diabetes Complications; 2023 Dec; 37(12):108634. PubMed ID: 37918178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can metabolic syndrome predict the vulnerable plaque in patients with stable angina pectoris? Virtual histology-intravascular ultrasound analysis.
    Lee MG; Jeong MH; Kim DH; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2012 May; 59(3):266-74. PubMed ID: 22341056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.